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Kinasea b s t r a c t
Crk and CrkL adaptors play essential neuronal positioning roles downstream of Reelin-induced
Dab1 tyrosine phosphorylation. Recently we identiﬁed Cin85 to be a CrkL-SH3 binding partner from
embryonic murine brain while others found Cin85 binds directly to Dab1. Here using mass spec-
trometry, biochemical and mutational analyses we show that Dab1 suppresses Cin85 phosphoryla-
tion at Ser587. Furthermore a Cin85 Ser587 phosphomimetic disrupts the Dab1-Cin85 complex
without affecting the Cin85-CapZ complex. These data provide an early glimpse into how Cin85
phosphorylation might alter the composition of its scaffolding partners to regulate its diverse roles
including vesicular trafﬁcking, receptor endocytosis and actin remodeling.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
During central nervous system development newly born neu-
rons take fates dependent on instructional cues in their environ-
ments. Some instructional cues direct a neuron’s ultimate
position in the mature tissue. One such master positional cue is
the secreted glycoprotein Reelin. Reelin governs neuronal position-
ing throughout the central nervous system with its function most
readily evident in the cerebellum, cerebral cortex and hippocam-pus. In spite of major advances toward understanding Reelin sig-
naling [1–5], it remains only partially understood.
The canonical Reelin pathway clusters its receptors very low
density lipoprotein receptor (VLDLR) and ApoE receptor 2
(ApoER2) found on responsive cells [6]. Bound to Reelin receptors
intracellularly is the adaptor protein disabled-1 (Dab1). Reelin
receptor clustering leads to Dab1 tyrosine phosphorylation by
the Src family of tyrosine kinases (SFKs) [7–10]. At the level of
phosphotyrosyl-Dab1 (pY-Dab1) the pathway bifurcates with
Tyr185 and Tyr198 responsible for the recruitment and activation
of phosphatidylinositol 3-kinase (PI3K)-Akt signaling and Tyr220
and Tyr232 leading to the recruitment of the adaptor molecules
Crk and Crk-Like (CrkL) [11,12]. Genetic dissection of this bifurca-
tion indicates that both PI3K-Akt and Crk/CrkL binding are essen-
tial in Reelin signaling [11,13]. We have identiﬁed several Crk/
CrkL binding proteins that could serve as Reelin effectors in both
targeted [12] and large-scale proteomic analyses [14]. We hypoth-
esized that Crk/CrkL could recruit effector proteins to the Reelin
signaling complex where they could be locally regulated by either
PI3K-Akt signaling or by SFKs. Indeed we found that the Crk/CrkL
binding partner C3G became tyrosine phosphorylated in response
to Reelin and this led to activation of the small G protein Rap1
[12]. Among the proteins from embryonic murine brain extracts
that we found bound to the CrkL-SH3 domain was the Cbl-interact-
ing protein of 85 kDa (Cin85) [14]. Intriguingly, Sato et al. found
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that this interaction was disrupted when Dab1 was phosphory-
lated by Cyclin-dependent kinase 5 [15], a kinase that plays critical
roles in brain development (reviewed in [16]).
Taken together these data suggest that Cin85 might participate
in Reelin signaling in a highly regulated way and we therefore
asked if Cin85 became phosphorylated at tyrosine residues or in
an Akt consensus motif in a setting where Reelin-Dab1 signaling
was engaged. To our surprise we found that Dab1 reduced Cin85
phosphorylation in an Akt-like motif. We identiﬁed the primary
site of this regulated phosphorylation to be Ser587. Furthermore
we found that a Ser587 Cin85 phosphomimetic showed dramati-
cally reduced binding to Dab1. The implications of the regulated
Cin85-Dab1 complex are discussed.
2. Materials and methods
2.1. Plasmids and site-directed mutagenesis
The Flag-CIN85 expression construct was a gift of Dr. Ivan Dikic
(Goethe University school of Medicine), the FKBP-Dab1-WT and
FKBP-Dab1-5F expression constructs were gifts of Dr. Johannes
Nimpf (Max Perutz Laboratories), and the Myr-Akt-HA construct
was a gift of Phil Tsichlis (Tufts University Medical School). The fol-
lowing constructs were generated using a QuikChange site directed
mutagenesis kit (Stratagene, La Jolla, CA): Flag-CIN85-DCT
(Ser587STOP) and Flag-Cin85 Pro492Ala. DNA sequence conﬁrma-
tion was performed by the University of Vermont Advanced Gen-
ome Technologies Core. Flag-Cin85 Ser587 Ala and Flag-Cin85
Ser587Asp were generated and sequenced-veriﬁed by Bio Basic
(Markham, ON).Fig. 1. Dab1 negatively regulates Cin85 phosphorylation in a RXXS/T motif. (A) The neg
tyrosine phosphorylation. HEK 293 cells were transfected with the indicated construct
Clariﬁed extracts were either directly subjected to SDS–PAGE and immunoblotting with
HEK 293 cells were transfected with Flag-Cin85, starved of serum and treated with or with
treated as in A. (C) HEK 293 cells were transfected with the indicated constructs. Co-trans
A) of FKBP-Dab1. (D) Flag-Cin85 was immunoprecipitated from transfected cells, subjecte
10% of the immune complexes were subjected to immunoblotting with the indicated an2.2. Mammalian cell culture, transfections, inhibitors, stimuli, and lysis
E1 A-transformed Human embryonic kidney (HEK 293E) cells
were grown in DMEM (Mediatech, Manassas, VA) supplemented
with 5% Fetal Bovine Serum (FBS), 5% Cosmic Calf Serum (sera were
from Hyclone, Logan, UT), 50 units/ml of penicillin and 50 lg/ml of
streptomycin. The cells were transfected by calcium phosphate
precipitation when at 75% of conﬂuence and between 6 and 16 h
after plating. Cells were washed with warm PBS 4 h after transfec-
tion and returned to full growth media for 72 h. In the case of stim-
ulations, cells were washed once with PBS and returned to media
without serum for 12 h prior to treatments as indicated in the ﬁg-
ure legends. Stimuli and inhibitors were used at the following con-
centrations and were from the following sources: Calyculin A
(100 nM), epidermal growth factor (EGF, 100 nM), Phorbol 12-myr-
istate 13-acetate (PMA, 100 nM) were from Cell Signaling Technol-
ogy (Danvers, MA). AP20187 (200 nM) was from ARIAD
Pharmaceuticals (Cambridge, MA). The CaMKII inhibitor (CK-59,
500 nM) was from Calbiochem (San Diego, CA). After treatments
cells were washed once in ice-cold PBS and lysed in ice-cold lysis
buffer (25 mM Tris pH 7.2, 137 mM NaCl, 10% glycerol, 1% Igepal,
25 mM NaF, 10 mM Na4P2O7, 1 mM Na3VO4, 1 mMP MSF, 10 lg/
mL leupeptin, and 10 lg/mL pepstatin). The insoluble material
was cleared using a tabletop micro-centrifuge at 13,000 rpm for
30 min at 4 C and the clariﬁed supernatant was kept for biochem-
ical analyses.
2.3. Antibodies, immunoprecipitations and immunoblotting
The anti-CIN85 (H-300), anti-Dab1 (H-103) and anti-CapZ
(130309) antibodies were from Santa Cruz Biotechnology (Santa
Cruz, CA). The anti-Flag M2 antibody and anti-Flag M2 afﬁnityative regulation of Cin85 RXXS/T phosphorylation by Dab1 is independent of Dab1
s, starved of serum and treated with AP20187 (200 nM) for 30 min prior to lysis.
the indicated antibodies or ﬁrst to anti-Flag immunopreciptation as indicated. (B)
out 100 nM Calyculin A for 30 min prior to lysis as indicated. Clariﬁed extracts were
fected 10 cm dishes received 15 lg of Flag-Cin85 and either zero, 5 lg or 10 lg (as in
d to SDS–PAGE and stained with coomassie blue (upper panel). Whole cell extract or
tibodies.
Fig. 2. Serine 587 is the primary Cin85 phosphorylation site recognized by the anti-phospho-RXXS/T motif antibody from growing HEK 293 cells. (A) Low energy collision-
induced dissociation (CID) MS/MS spectrum identiﬁed from peptides extracted following in-gel tryptic digestion of the Flag-Cin85 band shown in Fig. 1D. Compare this
spectrum to the spectrum from the unphosphorylated peptide shown in Fig. S1. (B) Schematic of the domain structure of Cin85. The three Src homology 3 (SH3) domains are
depicted as well as a proline-rich (PR) region. The dark box in the PR region indicates the CapZ binding region. CC indicates the coiled-coil domain. (C) Cells were transfected
with the indicated constructs and experiments were conducted as described in the legend to Fig. 1B. Fold changes in phospho-Cin85 levels relative to Flag-Cin85 levels and
sample type are indicated. (D) Cells were transfected with the indicated constructs (S/A indicates Ser587Ala) and experiments were conducted as described in Fig. 1 A. Fold
changes in phospho-Cin85 levels relative to Flag-Cin85 levels and sample type are indicated.
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(4G10) was from Upstate Biotechnology/Milipore (Billerica, MA).
Anti-phospho-Akt substrate (9611), anti-alpha tubulin (DM1A)
and anti-phospho-Thr202/Tyr204-ERK1/2 (E10) antibodies were
from Cell Signaling Technology (Danvers, MA). The anti-HA anti-
body (Clone 16B12) was from Covance (Princeton, NJ). The anti-
ERK1/2 antibody was a gift of John Blenis (Harvard Medical
School). Anti-rabbit IgG and anti-mouse IgG secondary antibodies
conjugated to horse radish peroxidase (HRP) were obtained from
Chemicon/Millipore (Billerica, MA). Immunoprecipitations were
conducted using 250–500 lg of whole cell extract and 30 ll of
packed anti-Flag afﬁnity resin except for the immunoprecipitations
prior to mass spectrometry where 2 mg of whole cell extract were
used. Immunoprecipitations rocked overnight at 4 C and were
washed three times with lysis buffer prior to SDS–PAGE using
10% (37.5:1 acrylamide:bis-acrylamide) polyacrylamide gels.
Immunoblotting was conducted as described previously [7].
Brieﬂy, proteins were transferred to nitrocellulose membranesand then blocked using 5% dry milk for 45 min in tris-buffered sal-
ine containing 0.05% Tween-20 (TBST). Primary antibodies were di-
luted in TBST containing 1.5% BSA and allowed to incubate on the
membranes for 2–12 h. Membranes were washed ﬁve times (5–
10 min each) with TBST prior to incubation with HRP-conjugated
secondary antibodies for 1–2 h. After ﬁve ﬁnal TBST washes the
membranes were subjected to enhanced chemiluminescence
(ECL) reagents (Pierce, Rockford, IL) and exposure to X-ray ﬁlm
(Denville scientiﬁc, Metuchen, NJ). Immunoblots were quantiﬁed
in Adobe Photoshop after converting images to inverted histo-
grams. Phosphosignals above background were normalized to
anti-Flag Cin85 levels.
2.4. Mass spectrometry
Immunopuriﬁed Flag-Cin85 was excised from the coomassie-
stained polyacrylamide gel and subjected to in-gel tryptic diges-
tion as described previously [17]. Extracted peptides were sub-
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(Thermo Electron, San Jose, CA) as described previously [17]. Tan-
dem mass spectra were searched using SEQUEST against a human
Cin85 amino acid sequence database requiring no enzyme speciﬁc-
ity, a 2 Da precursor mass tolerance and allowing for the following
differential mass modiﬁcations: methionine oxidation (+16); phos-
phorylation on serine, threonine and tyrosine (+80); and acrylam-
ide adduction on cysteine (+71).
3. Results
3.1. Dab1 negatively regulates Cin85 phosphorylation in anAkt-like
consensus motif
To test the hypothesis that Cin85 could be phosphorylated by
SFKs or Akt when Reelin signaling is active, we used a Dab1 dimer-
ization construct developed in the lab of Johannes Nimpf [6]. In this
construct wildtype Dab1, or a form of Dab1 that cannot be phos-
phorylated at Reelin-induced tyrosine phosphorylation sites
(Dab15F), is fused to FKBP. The resultant proteins expressed in
mammalian cells can be acutely dimerized by a bivalent small mol-
ecule (AP20187) capable of binding to FKBP [18]. This system was
shown to mimic Reelin receptor clustering as dimerized wildtype
Dab1-FKBP, but not Dab15F-FKBP, led to SFK-dependent Dab1 tyro-
sine phosphorylation and the activation of Akt in non-neuronal cell
lines [6]. We co-expressed Flag-tagged Cin85 with either wildtype
Dab1-FKBP or Dab15F-FKBP, induced dimerization and immuno-
precipitated Flag-Cin85. The immune complexes were probed with
anti-phosphotyrosine antibodies and anti-phospho-Akt substrate
minimal motif (RXXS/T) antibodies. While no signal was observed
in the anti-phosphotyrosine blot (not shown), we were surprised
to see a decrease, not an increase, in the phosphorylation of
Cin85 when using the anti-phospho-RXXS/T motif antibody
(Fig. 1A). Furthermore, this decrease in Cin85 phosphorylation
was independent of the phosphorylation state of Dab1 as the re-
sults were the same when co-expressing either wildtype-Dab1-
FKBP or Dab15F-FKBP (Fig. 1A). We conﬁrmed the co-immunopre-
cipation of Dab1 and Cin85 [15] and that only wildtype-Dab1-FKBP
was tyrosine phosphorylated (Fig. 1A). We also conﬁrmed thatFig. 3. Examination of potential Cin85 phospho-RXXS/T kinases. (A) HEK 293 cells were
indicated). Cells were starved of serum for 12 h, left untreated or treated with 100 nM
immunoblotting or ﬁrst to anti-Flag immunoprecipitation as indicated. (B) HEK 293 cell
without the CamKII inhibitor CK59 (500 nM for 30 min).Cin85 exhibited reversible phosphorylation in a RXXS/T motif by
a kinase endogenous to HEK293 cells. This was achieved indepen-
dently of clustering by treating cells transfected with Flag-Cin85
with the serine/threonine phosphatase inhibitor Calyculin A, fol-
lowed by anti-Flag immunopuriﬁcation and blotting with the
anti-phospho-RXXS/T motif antibody (Fig. 1B). We next demon-
strated that increasing concentrations of co-transfected Dab1 led
to increasingly diminished anti-phospho-RXXS/T signal on immu-
noprecipitated Flag-Cin85 (Fig. 1C). Toward the identiﬁcation of
the phosphorylated serine residue on Cin85 which was negatively
regulated by Dab1 we immunopuriﬁed coomassie-stainable levels
of Flag-Cin85 for mass spectrometry analysis (Fig. 1D).
3.2. Serine 587 is the primary Cin85 phosphorylation site recognized
by the phospho-RXXS/T motif antibody
The immunopuriﬁed Flag-Cin85 from Fig. 1D was cut from the
SDS–PAGE gel, subjected to in-gel tryptic digestion and liquid chro-
matography tandem mass spectrometry in a linear ion trap mass
spectrometer. One tryptic phosphopeptide was conﬁdently identi-
ﬁed corresponding to the CIN85 sequence R/AN(pS)PSLFGTEGKPK/
(Fig. 2A) where pS indicates phosphorylated serine 587 and R/ and
K/ indicate the sites of tryptic cleavage. Ser587 lies in a RXXS/T mo-
tif and would likely be recognized by the phospho-RXXS/T motif
antibody. The peptide identiﬁcation, and phosphorylation site
assignment as Ser587, and not as Ser589 or Thr593 were unequiv-
ocal. This is most readily shown by the prominent y-11 daughter
ion generated by fragmentation at the fragile site amino-terminal
to the proline at position four, which was also observed in the
spectrum of the unphosphorylated tryptic peptide harboring
Ser587 (Fig. S1). In the domain structure of Cin85 Ser587 is situ-
ated between a proline-rich region and a coiled-coil domain
(Fig. 2B). To determine if Ser587 was the primary phospho-RXXS/
T site in Cin85 recognized by the motif-speciﬁc antibody we ﬁrst
compared the phospho-RXXS/T signal of immunopuriﬁed wildtype
Cin85 and a Ser587 Stop truncation mutant from cells with or
without Calyculin A treatment following starvation of serum for
twelve hours. Both the baseline phospho-RXXS/T signal from un-
treated cells as well as the signal following Calyculin A treatmenttransfected with wildtype Cin85 (or co-transfected with myristoylated-Akt-HA as
EGF or PMA for 30 min as indicated. Whole cell extracts were directly subjected to
s were treated as in A except following serum starvation, cells were treated with or
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pared to wildtype Cin85 (Fig. 2C). Furthermore, a Cin85 Ser587Ala
mutant also showed greatly diminished anti-phospho-RXXS/T
reactivity (Fig. 2D). Taken together these data suggest that
Ser587 is the primary but not the only Cin85 phosphorylation site
that falls within a RXXS/T motif. Indeed, phosphositeplus [19] re-
ports the identiﬁcation of four other Cin85 phosphorylation sites
in addition to Ser587 that lie in a RXXS/T motif (Thr179, Ser230,
Ser436 and Ser493). Phosphorylation of Ser230 has been identiﬁed
in 28 studies, compared to 17 studies for Ser587, six studies for
Ser436 and one study each for Thr179 and Ser493. Additionally,
six other Cin85 phosphorylation sites have been identiﬁed that
lie in either a KXXS or KXXT motif to which the antibody has some
afﬁnity and which could contribute to the overall phospho-RXXS/T
signal.Fig. 4. A Cin85 Ser587Asp phosphomimetic exhibits dramatically reduced binding to Dab
Flag-Cin85 constructs and FKBP-Dab1 were lysed and extracts were either directly subje
subjected to anti-Flag immunoprecipitations. (B) Schematic depicting the domain structu
to CapZ. (C) Cin85 Pro492Ala is dramatically impaired in its ability to bind CapZ. HEK 29
were subjected directly to immunoblotting or ﬁrst to anti-Flag immunoprecipitations a3.3. Examination of potential Cin85 RXXS/T motif kinases
Toward the identiﬁcation of the possible kinase(s) involved in
the phosphorylation of Cin85 RXXS/T motifs we ﬁrst tested the ef-
fect of depriving cells of serum and then stimulating with factors
known to activate several basophilic kinases that target RXXS/T
motifs. Stimulation with epidermal growth factor (EGF) or the
phorbol ester PMA variably activates several basophilic kinase
families including Akt, RSK, MSK, S6K and PKC. However, stimula-
tion with EGF or PMA did not increase Cin85 phosphorylation in a
RXXS/T motif (Fig. 3A). EGF and PMA were shown to be active in
the system by the strong induction of activation loop phosphoryla-
tion on ERK1/2 (Fig. 3A). Furthermore, because this study began
with the hypothesis that Akt might induce Cin85 phosphorylation
we also speciﬁcally asked if co-transfection of Cin85 with an acti-1 but retains its binding to CapZ. (A) HEK 293 cells co-transfected with the indicated
cted to SDS–PAGE and immunoblotting with the indicated antibodies or were ﬁrst
re of Cin85 highlights the amino acids critical (underlined) for the binding of Cin85
3 cells were transfected with the indicated Flag-Cin85 constructs and cell extracts
s indicated.
Fig. 5. (A) Simple model depicting phospho-dependent regulation of the Dab1-Cin85 protein complex. Dab1 phosphorylation by Cdk5 at Ser400 and Ser491 disrupts its
binding to Cin85. Conversely, phosphorylation of Cin85 at Ser587 disrupts its binding to Dab1. Upon Reelin stimulation Cin85 levels could increase in proximity of the Reelin
signaling complex via recruitment to pY-Dab1 through the Crk/CrkL family of adaptors. Ultimately phsphotyrosyl-Dab1 is targeted for proteasome-dependent degradation
and Cin85 phosphorylation at Ser587 can accumulate. It is hypothesized that phospho-Ser587 Cin85 regulates its role in receptor endocytosis or actin cytoskeletal
remodeling. (B) Multiple sequence alignment shows Ser587 lies in a RXXSPS motif conserved among Cin85 orthologues in common vertebrates. The black arrow above the
alignment indicates the position of Ser587. ‘‘^’’ markings below the alignment indicate the positions of previously identiﬁed phosphorylation sites. Letters preceding
sequences indicate the ﬁrst letter of both the genus and species of the Cin85 orthologues (human, rat, mouse, chicken, frog, zebraﬁsh).
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RXXS/T motif in unstimulated cells. It did not (Fig. 3A). One of
the large-scale phosphoproteomic studies that identiﬁed Cin85
Ser587 phosphorylation suggested that this site might be phos-
phorylated by CamKII [20]. We therefore examined the effect of
the CamKII inhibitor CK59 [21] on Cin85 phosphorylation in a
RXXS/T motif. While CK59 signiﬁcantly reduced phospho-RXXS/T
in the whole cell extract, CK59 did not reduce Cin85 phosphoryla-
tion in a RXXS/T motif (Fig. 3B). While these results reduce the list
of possible Cin85 RXXS/T kinases, they remain to be identiﬁed.
3.4. A Cin85 Ser587Asp phosphomimetic dramatically reduces Dab1
binding but not CapZ binding to Cin85
Given the precedent that Cdk5 phosphorylation of Dab1 reduces
the binding of Dab1 to Cin85 [15], we asked if a Cin85 Ser587Asp
phosphomimetic would exhibit reduced binding to Dab1 in reci-
procal fashion. Indeed the Ser587Asp but not the Ser587Ala
showed dramatically reduced binding to Dab1 without affecting
the binding of Cin85 to another of its interacting partners CapZ
(Fig. 4A). CapZ has previously been shown to bind to a Cin85-re-lated protein CD2AP via a 17 residue stretch containing several
conserved residues also found in Cin85 (Fig. 4B). To test the
requirement of this conserved region in the binding of CapZ to
Cin85 while at the same time providing contrast to lack of effect
of the Ser587Asp mutation on the Cin85-CapZ interaction, we
showed that a single Ser492Ala mutation in Cin85 dramatically re-
duced its binding to CapZ (Fig. 4C). This suggests Ser587 of Cin85
lies in a unique and functionally distinct regulatory region.
4. Discussion
Our original hypotheses centered on the idea that Cin85 recruit-
ment to Reelin signaling complexes would enable Cin85 to become
locally phosphorylated by either active SFKs or Akt. Furthermore,
we anticipated that Cin85 might be involved in the canonical neu-
ronal positioning aspects of Reelin signaling. This latter concept
was in part suggested by the fact that the interaction of Cin85
could be disrupted by Cdk5 phosphorylation of Dab1 [15] and
Cdk5 deﬁciencies exhibit dramatic developmental defects that
have similarities to Reelin deﬁciencies [16]. However, neither of
these notions appears to be experimentally substantiated. Indeed,
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was explored by targeted genetic disruption of the neuronal iso-
forms of Cin85 [22]. In these animals no overt Reeler-like pheno-
type was observed, including no hypoplasia of the cerebellum
and its associated loss of motor control. However, genetic disrup-
tion of Cin85 in the brain revealed Cin85 had important postsynap-
tic roles, particularly in the regulation of dopamine receptor
trafﬁcking [22]. This shifts the possible connection between
Cin85 and Reelin signaling away from primary cytoarchitectural,
developmental effects and more toward synaptic regulation.
Intriguingly, both Cin85 and Reelin signaling components are
localized in postsynaptic dendritic regions and Reelin has been
implicated in synaptic transmission and synaptic integrity [22–
24]. If so, Reelin signaling in these tissues may lead to Cin85
Ser587 phosphorylation as Reelin-dependent degradation of pY-
Dab1 proceeds (Fig. 5). In this regard, it is important to note that
reconstitution of Reelin signaling by synthetic clustering as shown
in Fig. 1A does not induce Dab1 degradation. Alternatively, synap-
tic activity could increase the activity of Cin85 Ser587 kinases
independently of Reelin and reduce the binding of Cin85 to Dab1,
potentially freeing Cin85 for alternative roles [25].
However, it is possible that the regulation of Cin85 by Dab1 re-
ﬂects the effect any number of Cin85 SH3 binding proteins [25]
may have including Dab2 which lacks the tyrosine phosphoryla-
tion sites of Dab1 and thus is not targeted for degradation in a sim-
ilar manner. If the relative abundance of Cin85 SH3 binding
proteins is high relative to Cin85 it would then be predicted that
Cin85 Ser587 phosphorylation would be low. It is anticipated that
Cin85 Ser587 phosphorylation plays an important role in govern-
ing the composition of proteins on, and the ultimate effect of, the
Cin85 scaffold. It therefore will be important to determine which
Cin85 binding proteins have altered binding to the Ser587Asp mu-
tant. Such a line of inquiry will likely prove revealing not only to
establish the function of Ser587 phosphorylation but as well for
the several other Cin85 phosphorylation sites [25] that have been
identiﬁed primarily via large-scale proteomic screens.
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